Patents by Inventor Pramod Bhaskar Kumar

Pramod Bhaskar Kumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ROR-gamma modulators and uses thereof
    Patent number: 11084784
    Abstract: The present invention relates to a compound of formula I, or an isotopic form, stereoisomer, a tautomer, a pharmaceutically acceptable salt, a solvate, a polymorph, a prodrug, N-oxide or S-oxide thereof; and processes for their preparation. The invention further relates to pharmaceutical compositions containing the compounds and their use in the treatment of diseases or disorders mediated by ROR?.
    Type: Grant
    Filed: March 25, 2015
    Date of Patent: August 10, 2021
    Assignee: PIRAMAL ENTERPRISES LIMITED
    Inventors: Rajiv Sharma, Bichismita Sahu, Sunil Vasantrao Mali, Deepak Singh, Pramod Bhaskar Kumar, Mahesh Dawange, Hitesh Mistry
  • Imidazopyridine derivatives
    Patent number: 8741932
    Abstract: The present invention relates to compounds of formula (I), wherein Ra, Rb, Rc, Rd, Re and Rf are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases mediated by phosphatidylinositol-3-kinase (PI3K), mammalian target of rapamycin (mTOR), Signal transducer and activator of transcription 3 (STAT 3), tumor necrosis factor-? (TNF-?), interleukin-6 (IL-6) or a combination thereof particularly in the treatment of cancer and inflammation.
    Type: Grant
    Filed: November 4, 2010
    Date of Patent: June 3, 2014
    Assignee: Piramal Enterprises Limited
    Inventors: Sanjay Kumar, Sivaramakrishnan Hariharan, Mandar Bhonde, Nilesh Dagia, Rajiv Sharma, Pallavi Hanmantrao Mane, Pramod Bhaskar Kumar
  • IMIDAZOPYRIDINE DERIVATIVES
    Publication number: 20120232072
    Abstract: The present invention relates to compounds of formula (I), wherein Ra, Rb, Rc, Rd, Re and Rf are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases mediated by phosphatidylinositol-3-kinase (PI3K), mammalian target of rapamycin (mTOR), Signal transducer and activator of transcription 3 (STAT 3), tumor necrosis factor-? (TNF-?), interleukin-6 (IL-6) or a combination thereof particularly in the treatment of cancer and inflammation.
    Type: Application
    Filed: November 4, 2010
    Publication date: September 13, 2012
    Applicant: PIRAMAL LIFE SCIENCES LIMITED
    Inventors: Sanjay Kumar, Sivaramakrishnan Hariharan, Mandar Bhonde, Nilesh Dagia, Rajiv Sharma, Pallavi Hanmantrao Mane, Pramod Bhaskar Kumar